Results 21 to 30 of about 11,077 (219)

Change in CDAI scores in patients with CD at baseline, 8, 30, and 54 weeks.

, 2023
Change in CDAI scores in patients with CD at baseline, 8, 30, and 54 weeks.
Tomoe Kazama (16436202), Mikihiro Fujiya (254888), Katsuyoshi Ando (8128809), Nobuhiro Ueno (346397), Keisuke Ishigami (15532557), Takahiro Ito (1659682), Masanori Nojima (52788), Atsuo Maemoto (5638376), Hiroshi Nakase (783451)   +8 more
core   +1 more source

Inter-rater agreement between CDAI and DAS 28 at 3-time points of disease activity assessment.

, 2022
Inter-rater agreement between CDAI and DAS 28 at 3-time points of disease activity assessment.
Keerthie Dissanayake (9047032), Jayampathy Dissanayake (14192806), Chandrika Jayasinghe (10035879), Priyani Wanigasekara (10035882), Ajith Sominanda (10035885)   +4 more
core   +1 more source

Scatter plot illustrating linear positive correlation between DAS 28 and CDAI assessed at 3 time points (0 = 0 months, 4 = 4 months, 9 = 9 months).

, 2022
At all three time points of evaluation, CDAI was strongly correlated with DAS 28; ρ = 0.9357 at 0 months ...
Keerthie Dissanayake (9047032), Jayampathy Dissanayake (14192806), Chandrika Jayasinghe (10035879), Priyani Wanigasekara (10035882), Ajith Sominanda (10035885)   +4 more
core   +1 more source

Correlation between the relative proportion of each bacterium and CDAI up to 1 year after the start of the study.

, 2023
There was no correlation between Actinomyces or TM7-3 and CDAI. (TIF)
Daisuke Motooka (797341), Shinichiro Shinzaki (438567), Shunsuke Yoshii (1877350), Takahiro Amano (11369001), Shota Nakamura (182646), Tetsuo Takehara (425246), Taku Tashiro (11369004), Yoshiki Tsujii (6424070), Yuriko Otake-Kasamoto (15314630), Mizuki Tani (11369010), Takeo Yoshihara (11369016), Takahiro Inoue (128300), Hideki Iijima (6424064), Yoshito Hayashi (6424061), Akiko Asakura (15314627)   +14 more
core   +1 more source

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS

Научно-практическая ревматология, 2012
Objective — to evaluate the impact of tocilizumab (TCZ) therapy on progression of joint destruction and rheumatoid arthritis (RA) inflammatory activity in 48 weeks after initiation of treatment. Material and methods.
Anastasia Sergeevna Avdeeva, A V Smirnov, E Yu Panasyuk, E N Alexandrova, E L Nasonov   +4 more
doaj   +1 more source

Composite dietary antioxidant index was negatively associated with the prevalence of diabetes independent of cardiovascular diseases

Diabetology & Metabolic Syndrome, 2023
Aim The association between composite dietary antioxidant index (CDAI) and diabetes remains unknown. Our study was to investigate the association of CDAI with diabetes.
Xiaojie Chen, He Lu, Yingwei Chen, Haiqiang Sang, Yi Tang, Yifan Zhao   +5 more
doaj   +1 more source

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)

Научно-практическая ревматология, 2014
Objective. To evaluate the effectiveness and tolerance of Etanercept (ETN) therapy in patients with rheumatoid arthritis (RA).Material and Methods. 188 adult patients with severe and moderate RA (average DAS28 score of 6.26±0.89) subcutaneously received ...
Anna Olegovna Pchelintseva, E Yu Panasyuk, O F Ryabitseva, V I Mazurov, I G Salikhov, A E Sizikov, O N Ivanova, V N Sorotskaya, O V Semagina, I V Vinogradova, A I Kulikov, L N Denisov, E L Nasonov   +12 more
doaj   +1 more source

Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study

Open Access Rheumatology: Research and Reviews, 2021
Mohammed AlOmair,* Hanan AlMalki,* Nouf AlShamrani, Ghadah Habtar, Maram AlAsmari, Wejdan Mobasher, Hanan AlQahtani, Aydah Rahman, Alhussain Asiri Division of Rheumatology, Department of Medicine, Aseer Central Hospital, Abha, Saudi Arabia&ast ...
AlOmair M, AlMalki H, AlShamrani N, Habtar G, AlAsmari M, Mobasher W, AlQahtani H, Rahman A, Asiri A   +8 more
doaj  

Comparison of mean and maximal Crohn’s Disease Activity Index (CDAI) and Modified Truelove and Witts Activity Index (MTWAI) in patients with and without stoma.

, 2022
Comparison of mean and maximal Crohn’s Disease Activity Index (CDAI) and Modified Truelove and Witts Activity Index (MTWAI) in patients with and without stoma.
Babara Dora (13813050), Sabine Burk (13813047), René Roth (10106507), Michael Scharl (139957), Roland von Känel (111523), Gerhard Rogler (139954), Jean-Benoit Rossel (3145257), Patrizia Kloth (13813053), Thomas Greuter (6527111), Benjamin Misselwitz (149517), Philipp Schreiner (6527108), Rahel Bianchi (13813041), Barry Mamadou-Pathé (13813044), Andreas Rickenbacher (10106501), Matthias Turina (10106504), Luc Biedermann (139959)   +15 more
core   +1 more source

Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)

Gastroenterology, 1979
A previous paper reported derivation of the Crohn's Disease Activity Index (CDAI) from data on 112 patients. We have now rederived the values of the eight coefficients of the CDAI using data from 1058 visits of patients enrolled in the National Cooperative Crohn's Disease Study and the Trial of Adjunctive Sulfasalazine in Crohn's Disease. The rederived
W R, Best, J M, Becktel, J W, Singleton
openaire   +2 more sources